213 related articles for article (PubMed ID: 1063589)
21. In vitro cellular immune reactivity of soluble antigens obtained from cultured leukemic cells in chronic myeloid leukemia.
Khare AG; Advani SH; Gangal SG
Indian J Exp Biol; 1981 Jun; 19(6):524-7. PubMed ID: 6944272
[No Abstract] [Full Text] [Related]
22. [Methodical investigations on the leucocyte-migration-test in capillary technique (author's transl)].
Kirschnik AM; Bergmann KC; Kramer H
Z Erkr Atmungsorgane; 1980; 154(1):78-83. PubMed ID: 7434821
[TBL] [Abstract][Full Text] [Related]
23. In vitro detection of cell-mediated immunity to antigens associated with Hodgkin's granulomas.
Andersen E
Scand J Haematol; 1977 Apr; 18(4):343-7. PubMed ID: 857295
[TBL] [Abstract][Full Text] [Related]
24. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
25. Response to neoplastic antigens in human oncology: assessment and results of LIF (leucocyte inhibitory factor) test in breast cancer patients.
Mantovani G; Maxia G; Caporelli S; Cossu F; Sestu M
Tumori; 1978 Oct; 64(5):487-94. PubMed ID: 746596
[TBL] [Abstract][Full Text] [Related]
26. Cellular immunity to possible synovial antigens in rheumatoid arthritis.
Robinson AD; Muirden KD
Ann Rheum Dis; 1980 Dec; 39(6):539-44. PubMed ID: 7458429
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of leucocyte migration inhibition by breast tumour cell fractions.
Jones BM
Br J Cancer; 1976 Jul; 34(1):14-9. PubMed ID: 952712
[TBL] [Abstract][Full Text] [Related]
28. Study of cellular immunity in rheumatoid arthritis: inhibition of leucocyte migration by a synovial extract.
Kahan A; Alcalay M; Amor B; Delbarre F
Biomedicine; 1975 Apr; 23(3):111-5. PubMed ID: 1222225
[TBL] [Abstract][Full Text] [Related]
29. Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.
Brandes LJ; Goldenberg GJ
Cancer Res; 1976 Oct; 36(10):3707-10. PubMed ID: 953996
[TBL] [Abstract][Full Text] [Related]
30. Leukaemia antigens: mixed leucocyte culture tests on twelve leukaemic patients with identical twins.
Fefer A; Mickelson E; Thomas ED
Clin Exp Immunol; 1974 Oct; 18(2):237-42. PubMed ID: 4283118
[TBL] [Abstract][Full Text] [Related]
31. Leukocyte migration inhibition responses in canine lymphosarcoma.
Onions DE; Owen LN; Bostock DE
Int J Cancer; 1978 Oct; 22(4):503-7. PubMed ID: 581281
[TBL] [Abstract][Full Text] [Related]
32. [Leukocyte migration inhibition test in agarose: a method for the detection of cellular immunity in humans].
Alkan SS
Mikrobiyol Bul; 1976 Oct; 10(4):423-35. PubMed ID: 979705
[TBL] [Abstract][Full Text] [Related]
33. Cell-mediated immunity to hepatitis-associated antigen (HAA) demonstrated by leucocyte migration test during and after acute B hepatitis.
Frei PC; Erard P; Zinkernagel R
Biomedicine; 1973 Sep; 19(9):379-83. PubMed ID: 4791976
[No Abstract] [Full Text] [Related]
34. Leucocyte migration inhibition in Behçet's disease.
Haim S; Gilhar A; Mekori T; Segal R
Dermatologica; 1979; 159(4):302-6. PubMed ID: 478067
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of tumor-associated antigens on tumor cell hybrids by means of the leucocyte-migration-inhibition-test.
Cerni C
Oncology; 1977; 34(5):216-8. PubMed ID: 917455
[TBL] [Abstract][Full Text] [Related]
36. Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components.
Metzgar RS; Mohanakumar T; Bolognesi DP
J Exp Med; 1976 Jan; 143(1):47-63. PubMed ID: 53269
[TBL] [Abstract][Full Text] [Related]
37. Organ-related and malignancy-associated reactivity of cancer patients' leucocytes: a leucocyte migration study with tumour and foetal extracts.
Matzku S; Zöller M; Ikinger U; Price MR
Br J Cancer; 1980 Oct; 42(4):516-23. PubMed ID: 7437287
[TBL] [Abstract][Full Text] [Related]
38. Studies on antigens of C-type primate viruses and antibodies to them at patients with myeloid leukemia and potentially preleukemic hematological disorders.
Váczi L; Tóth FD
Arch Geschwulstforsch; 1980; 50(8):769-77. PubMed ID: 6261716
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immunity in idiopathic autoimmune haemolytic disease.
Slavin S; Aker M; Plesser YM; Rachmilewitz EA
Clin Exp Immunol; 1975 Mar; 19(3):445-50. PubMed ID: 1204245
[TBL] [Abstract][Full Text] [Related]
40. Leukaemia associated cell mediated immunity in household and hospital contents of chronic myeloid leukemia patients.
Gangal SG; Damle NK; Khare AG; Advani SH
Indian J Cancer; 1979 Mar; 16(1):55-62. PubMed ID: 396220
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
